Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hening Xu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the National Cancer Center|April 23, 2025
Ammonia-induced lysosomal and mitochondrial damage: a novel perspective on T cell-based cancer immunotherapyJianqiao Shentu, Hening Xu, Feng Zhu
Medcomm|May 22, 2025
Synergistic PD-1/LAG-3 Inhibition: Mechanistic Insights and Implications for Enhanced Tumor ImmunotherapyJianqiao Shentu, Hening Xu, Shiwei Duan
Apoptosis : an International Journal on Programmed Cell Death|February 1, 2026
VDAC2: an emerging pivotal and multifaceted regulator in tumor biologyJianqiao Shentu, Hening Xu, Ling Jin, et al.
Immunology|July 19, 2025
GD2-CAR T Cell Therapy for H3K27M<sup>+</sup> Diffuse Intrinsic Pontine Glioma: A Phase I Clinical Trial and Mechanistic InsightsCongfa Jiang, Hening Xu, Jianqiao Shentu, et al.
Stem Cells (Dayton, Ohio)|January 7, 2026
Circadian Timing Optimizes Allo-HSCT to Prevent aGVHD: A Breakthrough in Chrono-ImmunotherapyXiaguang Huang, Hening Xu, Yanru Xia, et al.
Journal of Translational Medicine|November 13, 2024
Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumorsYuqing Luo, Jianqiao Shentu, Hening Xu, et al.
Gene|March 22, 2025
miR-660: A novel regulator in human cancer pathogenesis and therapeutic implicationsZehua Wang, Xinming Su, Zhiqing Zhan, et al.
Gene|March 1, 2025
Unraveling the role of miR-767 in tumor progression: Mechanisms and clinical implicationsZheng Fu, Chenghong Jin, Sihan Yu, et al.
Plants (Basel, Switzerland)|September 28, 2023
An Interpretable High-Accuracy Method for Rice Disease Detection Based on Multisource Data and Transfer LearningJiaqi Li, Xinyan Zhao, Hening Xu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the National Cancer Center|April 23, 2025
Ammonia-induced lysosomal and mitochondrial damage: a novel perspective on T cell-based cancer immunotherapyJianqiao Shentu, Hening Xu, Feng Zhu
Medcomm|May 22, 2025
Synergistic PD-1/LAG-3 Inhibition: Mechanistic Insights and Implications for Enhanced Tumor ImmunotherapyJianqiao Shentu, Hening Xu, Shiwei Duan
Apoptosis : an International Journal on Programmed Cell Death|February 1, 2026
VDAC2: an emerging pivotal and multifaceted regulator in tumor biologyJianqiao Shentu, Hening Xu, Ling Jin, et al.
Immunology|July 19, 2025
GD2-CAR T Cell Therapy for H3K27M<sup>+</sup> Diffuse Intrinsic Pontine Glioma: A Phase I Clinical Trial and Mechanistic InsightsCongfa Jiang, Hening Xu, Jianqiao Shentu, et al.
Stem Cells (Dayton, Ohio)|January 7, 2026
Circadian Timing Optimizes Allo-HSCT to Prevent aGVHD: A Breakthrough in Chrono-ImmunotherapyXiaguang Huang, Hening Xu, Yanru Xia, et al.
Journal of Translational Medicine|November 13, 2024
Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumorsYuqing Luo, Jianqiao Shentu, Hening Xu, et al.
Gene|March 22, 2025
miR-660: A novel regulator in human cancer pathogenesis and therapeutic implicationsZehua Wang, Xinming Su, Zhiqing Zhan, et al.
Gene|March 1, 2025
Unraveling the role of miR-767 in tumor progression: Mechanisms and clinical implicationsZheng Fu, Chenghong Jin, Sihan Yu, et al.
Plants (Basel, Switzerland)|September 28, 2023
An Interpretable High-Accuracy Method for Rice Disease Detection Based on Multisource Data and Transfer LearningJiaqi Li, Xinyan Zhao, Hening Xu, et al.
Pageof 1